Feed aggregator

COVID-19 Vaccine Makers Top List of 2021’s Most Innovative Biotechs

Biospace news - Tue, 03/09/2021 - 02:00
In a list of the most innovative companies in 2021, Fast Company has outlined 10 biotech companies that continue to revolutionize the drug-discovery landscape.

COVID News: Pfizer-BioNTech Vaccine Effective Against Brazilian Variant and More

Biospace news - Tue, 03/09/2021 - 02:00
There was a little bit of positive COVID-19 news to report today. Here’s a look.

2021 Biopharma Update on the Novel Coronavirus: March 9

Biospace news - Tue, 03/09/2021 - 02:00
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 9, 2021.

New Drug Approval Could Be on Horizon for Alzheimer’s after 17-Year Drought

Biospace news - Tue, 03/09/2021 - 02:00
A drug to halt the progression of Alzheimer’s disease will likely be approved within the next three years, and Alzheon’s ALZ-801 might be the leading candidate.

CARB-X Places $22 Million Bet on Affinivax Staph Vaccine

Biospace news - Tue, 03/09/2021 - 02:00
Less than two months after bacterial vaccine company Affinivax’s Series C financing, the company is getting a $22 million boost from infectious disease consortium CARB-X to push forward a vaccine for tough-to-treat preclinical Staphylococcus aureus

Top 10 Most Expensive Drugs on the Market

Biospace news - Tue, 03/09/2021 - 02:00
Prescription drug watchdog GoodRx compiled a list of the 10 most expensive drugs on the market. The list includes drugs that can be acquired at the neighborhood pharmacy, as well as those only administered in a hospital setting.

EMA starts rolling review of the Sputnik V COVID-19 vaccine

World Pharma News - Mon, 03/08/2021 - 13:00
EMA's human medicines committee (CHMP) has started a rolling review of Sputnik V (Gam-COVID-Vac), a COVID-19 vaccine(1) developed by Russia's Gamaleya National Centre of Epidemiology and Microbiology. The EU applicant for this medicine is R-Pharm Germany GmbH.

Johnson & Johnson announces aingle-ahot Janssen COVID-19 vaccine candidate met primary endpoints in interim analysis of its Phase 3 ENSEMBLE trial

World Pharma News - Mon, 03/08/2021 - 11:00
Johnson & Johnson (NYSE: JNJ) (the Company) announced top line efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints.

Novartis signs initial agreement with CureVac to manufacture COVID-19 vaccine candidate

World Pharma News - Fri, 03/05/2021 - 11:00
Novartis has signed an initial agreement to manufacture the mRNA and bulk drug product for the COVID-19 vaccine candidate CVnCoV from CureVac to aid in the fight against the COVID-19 pandemic. Preparations for the start of production, technology transfer and test runs are already underway.

FDA Approves First Biologic for Rare, Debilitating Lung Disease

Biospace news - Fri, 03/05/2021 - 02:00
The U.S. FDA approved Genentech’s Actemra (tocilizumab) for slowing the rate of decline in pulmonary function in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD).

Former Portola CEO Takes the Helm at T-Cell Cancer Therapy Company

Biospace news - Fri, 03/05/2021 - 02:00
Scott Garland, the former chief executive officer of Portola Pharmaceuticals, will become the next CEO of South San Francisco-based PACT Pharma.

ABclonal Uses Fresh Funds to Buy Antibody CRO

Biospace news - Fri, 03/05/2021 - 02:00
Boston-based ABclonal Biotechnology acquired contract research organization (CRO) Yurogen Biosystems.

Proteomics Approach Finds Aggressive Cancer Drivers and Identifies Treatments

Biospace news - Fri, 03/05/2021 - 02:00
Baylor College of Medicine researchers suggest that the analysis of all protein data from aggressive human cancers could help identify novel treatment targets.

Researchers Make Headway on Universal Flu Vaccine Candidate

Biospace news - Fri, 03/05/2021 - 02:00
A recent study published in Science Translational Medicine shows that a new flu vaccine appears to protect monkeys against influenza strains that are likely to cause a global pandemic.

Failed Studies Shut Down COVID-19 Programs

Biospace news - Fri, 03/05/2021 - 02:00
Apellis Pharmaceuticals terminated its investigational COVID-19 asset after study data showed the therapeutic failed to reduce mortality rate in patients compared to standard of care.

Research Roundup: Putting a Number to COVID-19’s Transmissibility and More

Biospace news - Fri, 03/05/2021 - 02:00
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

BioSpace Movers & Shakers, March 5

Biospace news - Fri, 03/05/2021 - 02:00
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

Bharat’s Next-Gen COVID-19 Nasal Vaccine Moving Toward Human Testing

Biospace news - Fri, 03/05/2021 - 02:00
Days after vaccine-maker Bharat Biotech released interim Phase III efficacy data for a COVID-19 vaccine already in use in India, a pulmonary expert is expressing enthusiasm for the company’s next-generation intranasal vaccine on track to enter clinical testing this quarter.

New evidence COVID-19 antibodies, vaccines less effective against variants

World Pharma News - Thu, 03/04/2021 - 13:00
New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus that cause COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic. With few exceptions, whether such antibodies were produced in response to vaccination or natural infection, or were purified antibodies intended for use as drugs, the researchers found more antibody is needed to neutralize the new variants.